| 股票代码 | 股票名称 | 持有份额(万股) | 仓位比例 | 涨跌 | 贡献增长率 |
| 600276 | 恒瑞医药 | 30.7000 | 9.56% | 2.96% | 0.2830% |
| 688062 | 迈威生物 | 39.3400 | 9.33% | 1.77% | 0.1651% |
| 688266 | 泽璟制药 | 25.2300 | 9.21% | 4.38% | 0.4034% |
| 688443 | 智翔金泰 | 31.3300 | 8.55% | 0.20% | 0.0171% |
| 03692 | 翰森制药 | 74.0000 | 7.03% | 2.26% | 0.1589% |
| 688117 | 圣诺生物 | 29.3600 | 5.83% | 0.96% | 0.0560% |
| 02162 | 康诺亚-B | 25.6500 | 5.34% | -0.29% | -0.0155% |
| 688293 | 奥浦迈 | 19.9200 | 5.22% | 2.68% | 0.1399% |
| 01801 | 信达生物 | 15.6000 | 3.61% | 1.82% | 0.0657% |
| 688336 | 三生国健 | 20.4400 | 3.17% | 8.09% | 0.2565% |
| 重仓股仓位合计 | 重仓股贡献增长率 | 总持股仓位 | 修正增长率 | ||
| 66.85% | 1.5301% | 77.35% | |||
| 日期 | 实际增长率 | 预估增长率 |
| 2024-04-26 | 1.91% | 1.74% |
| 2024-04-25 | 1.16% | 0.80% |
| 2024-04-24 | 0.98% | 1.04% |
| 2024-04-23 | 3.79% | 3.95% |
| 2024-04-22 | 2.28% | 2.18% |
| 2024-04-19 | -1.51% | -2.17% |
| 2024-04-18 | -0.26% | -0.39% |
| 2024-04-17 | -0.10% | 0.07% |
| 基金名称 | 单位净值 | 日增长率 |
| 长盛城镇化主题混合C | 1.1636 | 6.8442% |
| 华泰柏瑞新经济沪港深混合C | 0.9412 | 6.1020% |
| 德邦鑫星价值C | 1.1751 | 6.0940% |
| 泰达宏利景气智选18个月持有混合A | 1.0058 | 5.9388% |
| 泰达宏利景气智选18个月持有混合C | 0.9995 | 5.9388% |
| 东吴双动力混合C | 0.5411 | 5.9371% |
| 泰达转型C | 2.2886 | 5.9046% |
| 东吴多策略C | 1.8144 | 5.8383% |
| 基金名称 | 单位净值 | 日增长率 |
| 东财数字经济混合发起式A | 0.9766 | 7.1883% |
| 东财数字经济混合发起式C | 0.9599 | 7.1883% |
| 长盛城镇化 | 1.1690 | 6.8442% |
| 长盛城镇化主题混合C | 1.1636 | 6.8442% |
| 华泰柏瑞新经济沪港深混合 | 0.9471 | 6.1020% |
| 华泰柏瑞新经济沪港深混合C | 0.9412 | 6.1020% |
| 德邦鑫星价值 | 1.2206 | 6.0940% |
| 德邦鑫星价值C | 1.1751 | 6.0940% |
